Embecta (EMBC) Stock Price, News & Analysis

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Embecta in the last twelve months. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street equities research analysts is that investors should "reduce" EMBC shares.
View EMBC analyst ratings or view top-rated stocks.

2 brokers have issued 1 year price targets for Embecta's shares. Their EMBC share price targets range from $16.00 to $16.00. On average, they expect the company's stock price to reach $16.00 in the next twelve months. This suggests a possible upside of 54.3% from the stock's current price.
View analysts price targets for EMBC or view top-rated stocks among Wall Street analysts.

Embecta's stock was trading at $18.93 at the beginning of the year. Since then, EMBC shares have decreased by 45.2% and is now trading at $10.37.
View the best growth stocks for 2024 here.

Embecta saw a decline in short interest in the month of April. As of April 15th, there was short interest totaling 2,540,000 shares, a decline of 17.3% from the March 31st total of 3,070,000 shares. Based on an average daily volume of 427,700 shares, the short-interest ratio is currently 5.9 days. Currently, 4.6% of the company's stock are sold short.
View Embecta's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, May 9th 2024.
View our EMBC earnings forecast.

Embecta will be holding an earnings conference call on Thursday, May 9th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link.

Embecta Corp. (NASDAQ:EMBC) issued its quarterly earnings data on Friday, February, 9th. The company reported $0.61 earnings per share for the quarter, beating analysts' consensus estimates of $0.46 by $0.15. The firm earned $277.30 million during the quarter, compared to analysts' expectations of $264.92 million. Embecta had a net margin of 4.93% and a negative trailing twelve-month return on equity of 18.66%. The firm's quarterly revenue was up .6% compared to the same quarter last year. During the same period last year, the business posted $0.93 EPS.

Embecta declared a quarterly dividend on Friday, February 9th. Shareholders of record on Wednesday, February 28th will be paid a dividend of $0.15 per share on Friday, March 15th. This represents a $0.60 dividend on an annualized basis and a dividend yield of 5.79%. The ex-dividend date of this dividend is Tuesday, February 27th.
Read our dividend analysis for EMBC.

Embecta (NASDAQ:EMBC) pays an annual dividend of $0.60 per share and currently has a dividend yield of 5.82%. EMBC has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 63.16%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, EMBC will have a dividend payout ratio of 27.15% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for EMBC.

ETFs with the largest weight of Embecta (NASDAQ:EMBC) stock in their portfolio include Syntax Stratified SmallCap ETF (SSLY) and Invesco S&P Spin-Off ETF (CSD).Simplify Health Care ETF (PINK).

Embecta updated its FY 2024 earnings guidance on Friday, February, 9th. The company provided EPS guidance of 1.950-2.150 for the period, compared to the consensus EPS estimate of 2.000. The company issued revenue guidance of $1.1 billion-$1.1 billion, compared to the consensus revenue estimate of $1.1 billion.

Embecta's stock is owned by a number of institutional and retail investors. Top institutional investors include Denali Advisors LLC (0.09%), Yousif Capital Management LLC (0.05%), Allspring Global Investments Holdings LLC (0.04%), Cardinal Capital Management (0.02%) and YHB Investment Advisors Inc. (0.01%). Insiders that own company stock include David F Melcher, Devdatt Kurdikar, Jacob Elguicze and Jeffrey Z Mann.
View institutional ownership trends.

Shares of EMBC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.